Patent · US Active

Antibody formulations and methods

US10513555B2 · kind B2 · utility

5Cited by

22References

23Claims

0Family size

Assignee

Prothena Biosciences Limited · IE

Inventors

Patrick Garidel · Norderstedt, DE
Andreas Langer · Munich, DE
Michael Grundman · San Diego, US

Key dates

Filing date	Jul 2, 2014
Grant date	Dec 24, 2019
Priority date	—
Expiry date	Dec 10, 2035

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/76
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention provides antibody formulations and methods useful for prophylaxis or treatment of synucleinopathies, including Parkinson's disease.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.